157 related articles for article (PubMed ID: 36463254)
1. The effect of mesenchymal stem cells-derived exosomes on the prostate, bladder, and renal cancer cell lines.
Rezaeian A; Khatami F; Heidari Keshel S; Akbari MR; Mirzaei A; Gholami K; Mohammadi Farsani R; Aghamir SMK
Sci Rep; 2022 Dec; 12(1):20924. PubMed ID: 36463254
[TBL] [Abstract][Full Text] [Related]
2. Human prostate cancer cell epithelial-to-mesenchymal transition as a novel target of arsenic trioxide and curcumin therapeutic approach.
Mirzaei A; Jahanshahi F; Khatami F; Reis LO; Aghamir SMK
Tissue Cell; 2022 Jun; 76():101805. PubMed ID: 35487055
[TBL] [Abstract][Full Text] [Related]
3. Novel combination therapy of prostate cancer cells with arsenic trioxide and flutamide: An in-vitro study.
Mirzaei A; Akbari MR; Tamehri Zadeh SS; Khatami F; Mashhadi R; Aghamir SMK
Tissue Cell; 2022 Feb; 74():101684. PubMed ID: 34800879
[TBL] [Abstract][Full Text] [Related]
4. Exosome carrying PSGR promotes stemness and epithelial-mesenchymal transition of low aggressive prostate cancer cells.
Li Y; Li Q; Li D; Gu J; Qian D; Qin X; Chen Y
Life Sci; 2021 Jan; 264():118638. PubMed ID: 33164833
[TBL] [Abstract][Full Text] [Related]
5. Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury.
Cao JY; Wang B; Tang TT; Wen Y; Li ZL; Feng ST; Wu M; Liu D; Yin D; Ma KL; Tang RN; Wu QL; Lan HY; Lv LL; Liu BC
Theranostics; 2021; 11(11):5248-5266. PubMed ID: 33859745
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin splice variants expression is involved on docetaxel resistance in PC3 prostate cancer cells.
Nakamura KD; Tilli TM; Wanderley JL; Palumbo A; Mattos RM; Ferreira AC; Klumb CE; Nasciutti LE; Gimba ER
Tumour Biol; 2016 Feb; 37(2):2655-63. PubMed ID: 26404131
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic potential of prostate carcinoma cells overexpressing bcl-2.
Fernandez A; Udagawa T; Schwesinger C; Beecken W; Achilles-Gerte E; McDonnell T; D'Amato R
J Natl Cancer Inst; 2001 Feb; 93(3):208-13. PubMed ID: 11158189
[TBL] [Abstract][Full Text] [Related]
8. Impact of umbilical cord mesenchymal stromal/stem cell secretome and cord blood serum in prostate cancer progression.
Sousa A; Coelho P; Leite F; Teixeira C; Rocha AC; Santos I; Baylina P; Fernandes R; Soares R; Costa R; Gomes A
Hum Cell; 2023 May; 36(3):1160-1172. PubMed ID: 36806993
[TBL] [Abstract][Full Text] [Related]
9. Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma.
Wang X; Wang X; Zhu Z; Li W; Yu G; Jia Z; Wang X
Biomed Pharmacother; 2019 Sep; 117():109109. PubMed ID: 31229922
[TBL] [Abstract][Full Text] [Related]
10. Antisense Bcl-2 sensitizes prostate cancer cells to radiation.
Mu Z; Hachem P; Pollack A
Prostate; 2005 Dec; 65(4):331-40. PubMed ID: 16015611
[TBL] [Abstract][Full Text] [Related]
11. Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer.
Cardoso HJ; Vaz CV; Correia S; Figueira MI; Marques R; Maia CJ; Socorro S
Prostate; 2015 Jun; 75(9):923-35. PubMed ID: 25786656
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the effect of secretome of human amniotic mesenchymal stromal cells on apoptosis induction and epithelial-mesenchymal transition inhibition in LNCaP prostate cancer cells based on 2D and 3D cell culture models.
Safari F; Shakery T; Sayadamin N
Cell Biochem Funct; 2021 Aug; 39(6):813-820. PubMed ID: 34128234
[TBL] [Abstract][Full Text] [Related]
13. Bim directly antagonizes Bcl-xl in doxorubicin-induced prostate cancer cell apoptosis independently of p53.
Yang MC; Lin RW; Huang SB; Huang SY; Chen WJ; Wang S; Hong YR; Wang C
Cell Cycle; 2016; 15(3):394-402. PubMed ID: 26694174
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of didscoidin domain receptor 1 reduces epithelial-mesenchymal transition and induce cell-cycle arrest and apoptosis in prostate cancer cell lines.
Azizi R; Salemi Z; Fallahian F; Aghaei M
J Cell Physiol; 2019 Nov; 234(11):19539-19552. PubMed ID: 30963567
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of anti-tumor activity of novel triazolo[1,5-a] pyrimidine on cancer cells by induction of cellular apoptosis and inhibition of epithelial-to-mesenchymal transition process.
Safari F; Bayat M; Nasri S; Karami S
Bioorg Med Chem Lett; 2020 May; 30(10):127111. PubMed ID: 32199733
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal Stem Cell-Derived Exosomes Attenuate Epithelial-Mesenchymal Transition of HK-2 Cells.
Yin S; Zhou S; Ren D; Zhang J; Xin H; He X; Gao H; Hou J; Zeng F; Lu Y; Zhang X; Fan M
Tissue Eng Part A; 2022 Jul; 28(13-14):651-659. PubMed ID: 35019728
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
19. Prostate tumor-induced angiogenesis is blocked by exosomes derived from menstrual stem cells through the inhibition of reactive oxygen species.
Alcayaga-Miranda F; González PL; Lopez-Verrilli A; Varas-Godoy M; Aguila-Díaz C; Contreras L; Khoury M
Oncotarget; 2016 Jul; 7(28):44462-44477. PubMed ID: 27286448
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone-releasing hormone (GHRH) promotes metastatic phenotypes through EGFR/HER2 transactivation in prostate cancer cells.
Muñoz-Moreno L; Bajo AM; Prieto JC; Carmena MJ
Mol Cell Endocrinol; 2017 May; 446():59-69. PubMed ID: 28193499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
